Cargando…

The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer

SIMPLE SUMMARY: The link between BRCA1/2 mutations and high susceptibility to breast cancer development has been well-established for years. However, the potential impact of BRCA1/2 mutations on the individual cell populations within the unique tumor microenvironment and their relation to breast can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miklikova, Svetlana, Trnkova, Lenka, Plava, Jana, Bohac, Martin, Kuniakova, Marcela, Cihova, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867315/ https://www.ncbi.nlm.nih.gov/pubmed/33540843 http://dx.doi.org/10.3390/cancers13030575

Ejemplares similares

Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer
por: Plava, Jana, et al.
Publicado: (2021)

Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer
por: Plava, Jana, et al.
Publicado: (2019)

Decreased levels of circulating cytokines VEGF, TNF-β and IL-15 indicate PD-L1 overexpression in tumours of primary breast cancer patients
por: Cierna, Zuzana, et al.
Publicado: (2021)

Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer
por: Miklikova, Svetlana, et al.
Publicado: (2020)

Permanent Pro-Tumorigenic Shift in Adipose Tissue-Derived Mesenchymal Stromal Cells Induced by Breast Malignancy
por: Plava, Jana, et al.
Publicado: (2020)

Increased Stromal Infiltrating Lymphocytes Are Associated with the Risk of Disease Progression in Mesenchymal Circulating Tumor Cell-Positive Primary Breast Cancer Patients
por: Smolkova, Bozena, et al.
Publicado: (2020)

A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease‐free survival in low‐risk breast cancer patients
por: Zmetakova, Iveta, et al.
Publicado: (2019)

Roles of the PARP Inhibitor in BRCA1 and BRCA2 Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor Microenvironment
por: Inoue, Takahiro, et al.
Publicado: (2023)

Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection
por: Ibrahim, Safinaz S, et al.
Publicado: (2010)

Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
por: Schmidtova, Silvia, et al.
Publicado: (2021)

Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
por: Lal, Avantika, et al.
Publicado: (2019)

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers
por: Vocka, Michal, et al.
Publicado: (2019)

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008)

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
por: Cipollini, G., et al.
Publicado: (1999)

A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population
por: Palomba, Grazia, et al.
Publicado: (2009)

Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
por: Skolekova, Svetlana, et al.
Publicado: (2016)

Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors
por: O’Sullivan, Ciara C., et al.
Publicado: (2014)

Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer
por: Machackova, Eva, et al.
Publicado: (2008)

BRCA Mutations and Breast Cancer Prevention
por: Kotsopoulos, Joanne
Publicado: (2018)

Alterations in the preneoplastic breast microenvironment of BRCA1/2 mutation carriers revealed by spatial transcriptomics
por: Caputo, Anthony, et al.
Publicado: (2023)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018)

Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
por: Pujol, Pascal, et al.
Publicado: (2022)

Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis
por: Tsyganov, Matvey M., et al.
Publicado: (2023)

Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling
por: Wei, Yousheng, et al.
Publicado: (2020)

Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
por: Launonen, I.-M., et al.
Publicado: (2022)

Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations
por: Birkbak, Nicolai Juul, et al.
Publicado: (2013)

Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer
por: Steinmann, D, et al.
Publicado: (2001)

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Rebbeck, Timothy R, et al.
Publicado: (2008)

Breast cancer prevention in women with a BRCA1 or BRCA2 mutation
por: Metcalfe, Kelly A, et al.
Publicado: (2007)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2012)

Prevalence of BRCA1 and BRCA2 Mutations in Korean Breast Cancer Patients
por: Ahn, Sei Hyun, et al.
Publicado: (2004)

Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer
por: Kim, Haeyoung, et al.
Publicado: (2013)

The importance of BRCA1 and BRCA2 genes mutations in breast cancer development
por: Mehrgou, Amir, et al.
Publicado: (2016)

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers
por: Arakelyan, Arsen, et al.
Publicado: (2021)

Looking for BRCA1 and BRCA2 mutations in Asian women with breast cancer
por: Narod, Steven A.
Publicado: (2023)

BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers
por: Loboda, Anna P., et al.
Publicado: (2023)

Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers
por: Rizzolo, Piera, et al.
Publicado: (2018)

BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.
por: Lancaster, J. M., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_7ur9qrkaavc3i065momrhh3t8p